Get the StoQuant digest — free

Free StoQuant digest by email. No account needed. See today's research picks.

Subscribe free

PHG vs SEPN — Stock Comparison

Compare PHG and SEPN side-by-side on StoQuant: PHG Q-Score 58 vs SEPN 45; analyst signal 56 vs 60. Plus alt data signals, insider buying, catalysts, strategic edges, short interest, social sentiment, and macro context.

Side-by-side snapshot

• PHG — Koninklijke Philips N.V. · Health Care · market cap $25.46B · Q-Score verdict Buy (58.0, grade B) · analyst signal 56/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: technicals 74/100, analyst consensus 39/100 · weakest signals: ML forecast 9/100. Full PHG research.
• SEPN — SEPTERNA INC · Health Care · Q-Score verdict Hold (45.0, grade C) · analyst signal 60/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: ML forecast 95/100, technicals 77/100 · weakest signals: earnings quality 45/100, competitive moat 24/100. Full SEPN research.

What you can compare

• Q-Score: StoQuant's composite 0–100 rating based on 140+ financial signals.
• Alt data signals: Google Trends, EDGAR 8-K filings, job postings, and more.
• Insider activity: Cluster scores and recent Form 4 buying.
• Catalysts: Earnings, analyst changes, M&A, clinical trials, and SEC events.
• Strategic edges: Competitive moat and durable advantage analysis.
• Short interest & social sentiment: Short % float, social mention volume, and bullish/bearish breakdown.
• Macro context: Market regime and sector rotation alignment.

Deep dive: PHG research · SEPN research. Sign in to StoQuant to run live comparisons for any tickers. Sign up free →